Transdermal delivery of carvedilol in rats: Probing the percutaneous permeation enhancement mechanism of soybean extractchitosan mixture Transdermal delivery of carvedilol

Drug Development and Industrial Pharmacy

Volumn 35, Issue 10, 2009, Pages 1230-1241

  Sapra, Bharti ^a   Jain, Subheet ^a   Tiwary, Ashok K ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

Differential scanning calorimetry; Pharmacokinetic; Saponin; Scanning electron microscopy; Solubility; Transmission electron microscopy

Indexed keywords

CARVEDILOL; CHITOSAN; CHOLESTEROL; DEOXYCORTICOSTERONE ACETATE; SPHINGOSINE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG HALF LIFE; DRUG METABOLISM; DRUG SOLUBILITY; EPIDERMIS; HYPERTENSION; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PARTITION COEFFICIENT; RAT; SCANNING ELECTRON MICROSCOPY; SKIN PERMEABILITY; SOYBEAN; SUSTAINED DRUG RELEASE; TIME TO MAXIMUM PLASMA CONCENTRATION; TRANSMISSION ELECTRON MICROSCOPY;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIHYPERTENSIVE AGENTS; CARBAZOLES; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; DELAYED-ACTION PREPARATIONS; DESOXYCORTICOSTERONE; DISEASE MODELS, ANIMAL; EPIDERMIS; EXCIPIENTS; FEMALE; HYPERTENSION; MALE; PERMEABILITY; PLANT EXTRACTS; PROPANOLAMINES; RATS; RATS, WISTAR; SKIN ABSORPTION; SOLUBILITY; SOYBEANS;

EID: 70350668809     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040902882272     Document Type: Article

References (35)

1. Klimentová J, Kosák P, Vávrová K, Holas T, Novotný J, Hrabálek A. (2008). Transkarbams with terminal branching as transdermal permeation enhancers. Bioorg Med Chem Lett, 18:1712-1715
2. Vávrová K, Lorencová K, Novotný J, Holý A, Hrabálek A. (2008). Permeation enhancer dodecyl 6-(dimethylamino)hexanoate increases transdermal and topical delivery of adefovir: Influence of pH, ion-pairing and skin species. Eur J Pharm Biopharm, 70:901-907
3. Vávrová K, Lorencová K, Klimentová J, Novotný J, Holý AN, Hrabálek A. (2008). Transdermal and dermal delivery of adefovir: Effects of pH and permeation enhancers. Eur J Pharm Biopharm, 69:597-604.
4. Novotný J, Kovaríková P, Novotný M, Janušová B, Hrabálek A, Vávrová K. (2008). Dimethylamino acid esters as biodegradable and reversible transdermal permeation enhancers: Effects of linking chain length, chirality and polyfluorination. Pharm Res, 26(4):811-821
5. Novotný M, Hrabálek A, Janušová B, Novotný J, Vávrová K. (2009). Dicarboxylic acid esters as transdermal permeation enhancers: Effects of chain number and geometric isomers. Bioorg Med Chem Lett, 19:344-347
6. Kaushik D, Batheja P, Kilfoyle B, Rai V, Michniak-Kohn B. (2008). Percutaneous permeation modifiers: Enhancement versus retardation. Expert Opin Drug Deliv, 5:517-529
7. Shah VP. (1994). Skin penetration enhancers: Scientific perspective. In: Hsieh DS, ed. Drug permeation and enhancement. New York: Marcel Dekker, 19-23.
8. Weerheim A, Ponec M. (2001). Determination of stratum corneum lipid profile by tape stripping in combination with highperformance thin-layer chromatography. Arch Dermatol Res, 293:191-199
9. Barry BW, Bennett SL. (1987). Effect of penetration enhancers on the permeation of mannitol, hydrocortisone and progesterone through human skin. J Pharm Pharmacol, 39:535-546
10. Bodde HE, Van den Brink I, Koerten HK, Dehaan FHN. (1991). Visualization of in vitro percutaneous penetration of mercuric chloride transport through intercellular space versus cellular uptake through desmosomes. J Control Release, 15:227-236
11. Elias PM. (1983). Epidermal lipids, barrier function, and desquamation. J Invest Dermatol, 80:44S-9S.
12. Babita K, Rana V, Tiwary AK. (2005). Lipid synthesis inhibitors: Effect on epidermal lipid conformational changes and percutaneous permeation of levodopa. AAPS PharmSciTech, 6:E473-81.
13. Kumar B, Tiwary AK. (2005). Transcutaneous delivery of levodopa: Enhancement by fatty acid synthesis inhibition. Mol Pharm, 2:57-63.
14. Davar K. (1997). Drug-surfactant interactions: Effect on transport properties. Int J Pharm, 155:179-190
15. Goodman M, Barry BW. (1988). Action of penetration enhancers on human skin as assessed by the permeation of model drugs 5-fluorouracil and estradiol. I. Infinite dose technique. J Invest Dermatol, 91:323-327
16. Bouwstra JA, Honeywell-Nguyen PL, Gooris GS, Ponec M. (2003). Structure of the skin barrier and its modulation by vesicular formulations. Prog Lipid Res, 42:1-36.
17. Smith J, Wood E, Dornish M. (2004). Effect of chitosan on epithelial cell tight junctions. Pharm Res, 21:43-49
18. Shigeru A, Yoshihiro U. (1985). Soybean saponins, and a method of isolating the same. US patent no. 4524067.
19. Kligman AM, Christophers E. (1963). Preparation of isolated sheets of human stratum corneum. Arch Dermatol, 88:702-705
20. Folch J, Lees M, Sloane-Stanley GH. (1957). A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem, 226:497-502.
21. Sabbadini R, McNutt WM, Jenkins G, Betto R, Salviati G. (1993). Sphingosine is endogenous to cardiac and skeletal muscle. Biochem Biophys Res Commun, 3:752-758
22. Singh S, Bi M, Jayaswal SB, Singh J. (1998). Effect of current density on the iontophoretic permeability of benzyl alcohol and surface characteristics of human epidermis. Int J Pharm, 166:157-166
23. Van den Bergh BAI, Swartzendruber DC, Geest AB, Hoogstraate JJ, Schrijvers AHGJ, Bodde HE, et al. (1997). Development of an optimal protocol for the ultrastructural examination of skin by transmission electron microscopy. J Microsc, 187:125-133
24. Rogiers V. (1995). TEWL-measurements in patch test assessment: The need for standardization. In: Elsner P, Maibach HI, eds. Irritant dermatitis, new clinical and experimental aspects (Current problems in Dermatology). Basel: Karger, 152-158
25. Khazaei M, Nematbakhsh M. (2006). The effect of hypertension on serum nitric oxide and vascular endothelial growth factor concentrations. A study in DOCA-salt hypertensive overiectomized rats. Regul Pept, 135:91-94
26. Nokhodchi A, Nazemiyeh H, Ghafourian T, Hassan-Zadeh D, Valizadeh H, Bahary LA. (2002). The effect of glycyrrhizin on the release rate and skin penetration of diclofenac sodium from topical formulations. Farmaco, 57(11):883-888
27. Shokri J, Nokhodchi A, Dashbolaghi A, Hassan-Zadeh D, Ghafourian T, Jalali MB. (2001). The effect of surfactants on the skin permeation of diazepam. Int J Pharm, 228:99-107.
28. Gibaldi M, Feldman S. (1970). Mechanisms of surfactant effects on drug absorption. J Pharm Sci, 59:579-589
29. Abrams K, Harvell JD, Shriner D, Wertz P, Maibach H, Maibach HI, Rehfeld SJ. (1993). Effect of organic solvents on in vitro human skin water barrier function. J Invest Dermatol, 101:609-613
30. Yamashita N, Tachibana K, Ogawa K, Tsujita N, Tomita A. (1997). Scanning electron microscopic evaluation of the skin surface after ultrasound exposure. Anat Rec, 247:455-461
31. Bouwstra JA, Cheng K, Gooris GS, Weerheim A, Ponec M. (1996). The role of ceramides 1 and 2 in the stratum corneum lipid organization. Biochim Biophys Acta, 1300:177-186
32. Lavker RM. (1979). Membrane-coating granules: The fate of the discharged lamellae. J Ultrastruct Res, 55:79-86.
33. Lampe MA, Williams ML, Elias PM. (1983). Human epidermal lipid characterization and modulation during differentiation. J Lipid Res, 24:131-140
34. Fujimaki M, Hakusui H, Hasegawa Y, Ajima H, Ota H, Igafashi S, et al. (1990). Pharmacokinetics of carvedilol (DQ-2466) in healthy subjects. Jpn J Clin Pharmacol Ther, 21:415-424
35. Hokama N, Hobra N, Kameya H, Ohshiro S, Sakanashi M. (1999). Rapid and simple micro-determination of carvedilol in rat plasma by high-performance liquid chromatography. J Chromatogr B, 732:233-238